心臟心律调节器市场规模、份额、成长分析，按类型、最终用户、地区 - 行业预测，2024-2031 年

Cardiac Pacemaker Market Size, Share, Growth Analysis, By Type (External Pacemakers, Implantable Pacemakers), By End User (Hospitals, Cardiac Clinics), By Region - Industry Forecast 2024-2031

出版日期: 2024年12月18日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5个工作天内

价格

简介目录

2022年全球心臟心律调节器市场规模估值为39.2亿美元，从2023年的40.4亿美元成长到2031年的51.6亿美元，在预测期间（2024-2031年）预计复合年增长率为3.1% 。

由于心血管疾病盛行率上升和人口老化，全球心臟心律调节器市场正在显着增长。生活方式改变等因素进一步增加心臟病的风险。技术的创新进步促进了微型无线心律调节器的发展，该起搏器具有远端监控功能和自动生理调节功能。新兴市场早期诊断意识的提高和医疗基础设施的改善也有助于市场扩张。此外，研发投资的增加以及设备製造商和医疗保健提供者之间的合作也刺激了成长。然而，高昂的移植成本和偏远地区的访问受限等挑战可能会阻碍市场成长。总体而言，由于持续的技术创新和向微创手术的转变，预计市场将显着成长。

北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 义大利
- 其他欧洲国家地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 其他亚太地区
拉丁美洲
- 巴西
- 其他拉丁美洲地区
中东/非洲
- 海湾合作委员会国家
- 南非
- 其他中东/非洲

竞争资讯

前5名企业对比
主要企业市场定位（2023年）
主要市场参与者所采取的策略
近期市场趋势
公司市场占有率分析（2023）
主要企业简介
- 公司简介
- 产品系列分析
- 按细分市场分類的份额分析
- 收益与前一年同期比较（2021-2023）

主要企业简介

Medtronic PLC
Abbott Laboratories
Boston Scientific Corporation
Biotronik SE & Co. KG
Lepu Medical Technology Co., Ltd.
LivaNova PLC
Osypka AG
Oscor Inc.
Pacetronix
Medico SRL
MicroPort Scientific Corporation
Shree Pacetronix Ltd.
ZOLL Medical Corporation
Asahi Kasei Corporation
OSYPKA Medical GmbH
Cardiac Science Corporation
EBR Systems, Inc.
BioTrace Medical, Inc.
Sorin Group（LivaNova）
Vitatron（Medtronic）

结论和建议

简介目录

Product Code: SQMIG35A2302

Global Cardiac Pacemaker Market size was valued at USD 3.92 billion in 2022 and is poised to grow from USD 4.04 billion in 2023 to USD 5.16 billion by 2031, growing at a CAGR of 3.1% during the forecast period (2024-2031).

The Global Cardiac Pacemaker Market is witnessing significant growth, driven by the rising prevalence of cardiovascular diseases and an aging population. Factors such as lifestyle changes are further escalating the risk of heart issues. Innovative advancements in technology have led to the development of smaller, wireless pacemakers featuring remote monitoring capabilities and automatic physiological adjustments. Increased awareness of early diagnosis and enhancements in healthcare infrastructure in developing regions also contribute to market expansion. Additionally, heightened investment in research and development, along with collaborations between device manufacturers and healthcare providers, is stimulating growth. However, challenges like high implantation costs and limited access in remote areas may hinder progress. Overall, the market is set for substantial growth due to ongoing innovations and a shift towards minimally invasive procedures.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Cardiac Pacemaker market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Cardiac Pacemaker Market Segmental Analysis

Global Cardiac Pacemaker Market is segmented by type, end user and region. Based on type, the market is segmented into external pacemakers and implantable pacemakers. Based on end user, the market is segmented into hospitals, cardiac clinics, ambulatory surgery centers and others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Cardiac Pacemaker Market

One of the primary factors propelling the Global Cardiac Pacemaker Market is the rising prevalence of cardiovascular diseases. As the occurrence of heart-related issues such as arrhythmias and heart failure escalates around the world, the demand for cardiac pacemakers to effectively manage and treat these ailments intensifies. This trend is further exacerbated by lifestyle factors such as sedentary behavior, poor dietary choices, and an aging demographic, all of which collectively increase the incidence and burden of cardiovascular diseases globally. Consequently, the heightened need for innovative cardiac solutions significantly drives market growth and expansion.

Restraints in the Global Cardiac Pacemaker Market

A significant constraint within the Global Cardiac Pacemaker market is the elevated expenses linked to pacemaker implantation procedures. These advanced medical devices necessitate expertise from trained medical professionals along with specialized equipment and comprehensive post-operative care. The cumulative costs-including the pacemaker itself, surgical expenses, hospitalization, and subsequent follow-up-can be quite high, imposing a heavy financial strain on many patients. This economic hurdle limits access to essential cardiac care, especially for individuals in lower-income areas or those lacking sufficient insurance coverage, ultimately hindering the overall growth of the market.

Market Trends of the Global Cardiac Pacemaker Market

A prominent trend in the Global Cardiac Pacemaker Market is the rising adoption of remote monitoring technologies. This shift is fueled by the demand for continuous patient oversight and the urgent need for early detection of device malfunctions and abnormalities. Remote monitoring solutions allow healthcare providers to assess and track pacemaker performance in real-time, significantly improving patient care through timely interventions and minimizing the necessity for frequent hospital visits. The integration of advanced communication technologies and wireless connectivity has streamlined data transmission, enhancing patient outcomes and engagement. As a result, remote monitoring is becoming an essential feature in cardiac care strategies, shaping the future landscape of the market.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2023
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Technological Advancement
Case Studies
Trade Analysis

Global Cardiac Pacemaker Market Size by Type & CAGR (2024-2031)

Market Overview
External Pacemakers
- Single Chamber
- Dual Chamber
Implantable Pacemakers
- Conventional
- Leadless

Global Cardiac Pacemaker Market Size by End User & CAGR (2024-2031)

Market Overview
Hospitals
Cardiac Clinics
Ambulatory Surgery Centers
Others

Global Cardiac Pacemaker Market Size & CAGR (2024-2031)

North America (Type, End User)
- US
- Canada
Europe (Type, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Type, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Type, End User)
- Brazil
- Rest of Latin America
Middle East & Africa (Type, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2023
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

Medtronic PLC
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott Laboratories
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Boston Scientific Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Biotronik SE & Co. KG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Lepu Medical Technology Co., Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
LivaNova PLC
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Osypka AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Oscor Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Pacetronix
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medico S.R.L.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
MicroPort Scientific Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Shree Pacetronix Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ZOLL Medical Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Asahi Kasei Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
OSYPKA Medical GmbH
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cardiac Science Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
EBR Systems, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BioTrace Medical, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sorin Group (LivaNova)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Vitatron (Medtronic)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments